This marks a significant step forward in providing Australian patients with cutting-edge genomic technology for personalized breast cancer care.

EndoPredict is specifically designed for patients with early-stage ER+/HER2- breast cancer, offering a highly personalized risk assessment for disease relapse.

With this genomic test, Australian healthcare providers can now offer their patients deeper insights, helping them in finding the most appropriate path for managing their disease

The availability of EndoPredict in Australia empowers patients by providing precise, clinically validated data that is tailored to their unique cancer profile.

NATA Accreditation, a Stamp of Quality for Australian Labs:

• The National Association of Testing Authorities, Australia (NATA), has accredited Australian Clinical Labs to process the EndoPredict test.
• This accreditation guarantees the highest standards in accuracy, reliability, and quality.
• Australian patients and clinicians can now trust that their EndoPredict results meet stringent local standards.

Medicare Benefits Schedule (MBS) Reimbursement:

• EndoPredict is now accessible on the Medicare Benefits Schedule (MBS) for eligible patients with early-stage breast cancer, offering a partial rebate.
• This inclusion greatly improves access to this advanced diagnostic tool, ensuring that more Australian breast cancer patients can benefit from its use.

What This Means for Australian Patients and Healthcare Providers:

• Personalized Care: EndoPredict provides a clear, individualized prognosis
• Local Processing with NATA Accreditation: Assurance of quality, accuracy, and reliability through Australian Clinical Labs.
• Improved Access: With Medicare rebate options, the test is now more financially accessible for eligible patients.

Eurobio is committed to continuing our work with in-country laboratories to support clinicians and patients in making the best decisions for their care with confidence in the data they receive.

To learn more or get access to EndoPredict in Australia, contact Australian Clinical Labs or reach out to us at info-int@eurobio-scientific.de.

About us: Eurobio Scientific è un'azienda globale con la missione di migliorare la qualità della vita dei pazienti attraverso diagnostici specialistici. La nostra visione è diventare un'azienda leader a livello mondiale nel campo della diagnostica specialistica, offrendo soluzioni altamente innovative ai professionisti sanitari per raggiungere questo obiettivo.

Con oltre 370 dipendenti in tutto il mondo, Eurobio Scientific si dedica a fornire supporto locale attraverso i nostri quattro centri di produzione, tre centri di ricerca e uffici locali in Francia, Paesi Bassi, Germania, Italia, Svizzera, Regno Unito e Stati Uniti.

Il nostro team esperto di ricerca e sviluppo accumula anni di esperienza nello sviluppo di test diagnostici molecolari avanzati nei campi del trapianto, dell'oncologia e delle malattie infettive.